Skip to content
DataLookout
Menu

NCT07243171

A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

StatusRecruiting
PhasePhase 1/2
Primary completion (estimated)

At risk: Primary completion moved at least 5 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Interventions modified
  2. Notable Enrollment increased: 84 → 126 participants
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 1 of 10 entries
    • Study description expanded, about 3 words
  3. Minor Primary completion pushed from Aug 3, 2026 to Jan 5, 2027
    • Study completion pushed from Nov 22, 2026 to Apr 28, 2027
    • Site contact updated
    v4
  4. Minor Site details revisedv3
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Eligibility criteria shortened, about 4 words
    • Start date changed from estimate of Nov 17, 2025 to Nov 18, 2025
    • Site details revised
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

The incidence and severity of adverse events
Timeframe: up to day 204

Secondary (10)

Pharmacokinetics of oral ecnoglutide tablet
Change of body weight from baseline
Change of BMI from baseline
Change of waist circumference from baseline
Change of hip circumference from baseline
Show 5 moreShow less
Change of neck circumference from baseline
Change of waist/hip ratio from baseline
Change of fasting blood glucose from baseline
Change of fasting insulin from baseline
Change of lipid profile from baseline

Arms and interventions

oral ecnoglutide C1Experimental

once daily, up-titration every 7 days, dosing for 21 days in total

oral ecnoglutide C2Experimental

once daily, up-titration every 7 days, dosing for 28 days in total

oral ecnoglutide C3Experimental

once weekly, up-titration every 2-4 weeks, dosing for 24 weeks in total

oral ecnoglutide C4Experimental

once weekly, up-titration every 2-4 weeks, dosing for 24 weeks in total

oral ecnoglutide C5Experimental

once weekly, up-titration every 4 weeks, dosing for 24 weeks in total

oral ecnoglutide C6Experimental

once daily, up-titration every 7 days, dosing for 28 days in total

Drugs: ecnoglutide tablets, placebo with matching dosage

Sites

1 site in 1 country

  • China-Japan Friendship HospitalBeijing, Beijing Municipality, China